Bath Savings Trust’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$466K Hold
8,080
0.05% 132
2026
Q1
$490K Sell
8,080
-663
-8% -$38.6K 0.05% 124
2025
Q4
$472K Buy
8,743
+198
+2% +$9.53K 0.05% 127
2025
Q3
$385K Hold
8,545
0.04% 134
2025
Q2
$396K Hold
8,545
0.04% 130
2025
Q1
$521K Sell
8,545
-650
-7% -$37.9K 0.05% 117
2024
Q4
$520K Sell
9,195
-400
-4% -$22.4K 0.05% 120
2024
Q3
$496K Sell
9,595
-260
-3% -$12.2K 0.05% 123
2024
Q2
$409K Sell
9,855
-100
-1% -$4.47K 0.04% 122
2024
Q1
$540K Sell
9,955
-379
-4% -$19.3K 0.06% 115
2023
Q4
$530K Sell
10,334
-1,210
-10% -$63.5K 0.06% 116
2023
Q3
$670K Sell
11,544
-1,700
-13% -$104K 0.08% 105
2023
Q2
$847K Sell
13,244
-100
-0.7% -$6.71K 0.1% 99
2023
Q1
$925K Sell
13,344
-200
-1% -$14.1K 0.11% 97
2022
Q4
$974K Sell
13,544
-664
-5% -$50.1K 0.13% 93
2022
Q3
$1.01M Buy
14,208
+868
+7% +$63K 0.14% 88
2022
Q2
$1.03M Sell
13,340
-110
-0.8% -$8.38K 0.14% 90
2022
Q1
$982K Sell
13,450
-450
-3% -$30.2K 0.11% 96
2021
Q4
$867K Sell
13,900
-3,212
-19% -$188K 0.09% 99
2021
Q3
$1.01M Buy
17,112
+223
+1% +$14.7K 0.12% 93
2021
Q2
$1.13M Sell
16,889
-2,445
-13% -$159K 0.13% 87
2021
Q1
$1.22M Sell
19,334
-1,459
-7% -$90.8K 0.16% 84
2020
Q4
$1.29M Sell
20,793
-1,685
-7% -$104K 0.17% 79
2020
Q3
$1.35M Sell
22,478
-245
-1% -$14.7K 0.22% 65
2020
Q2
$1.34M Sell
22,723
-987
-4% -$59K 0.24% 62
2020
Q1
$1.32M Sell
23,710
-450
-2% -$27.5K 0.29% 60
2019
Q4
$1.55M Buy
24,160
+7,375
+44% +$422K 0.28% 60
2019
Q3
$851K Sell
16,785
-323
-2% -$15.2K 0.16% 73
2019
Q2
$776K Buy
17,108
+568
+3% +$26.5K 0.15% 71
2019
Q1
$789K Buy
16,540
+100
+0.6% +$4.98K 0.17% 70
2018
Q4
$854K Sell
16,440
-245
-1% -$13.2K 0.21% 69
2018
Q3
$1.04M Buy
16,685
+348
+2% +$20.7K 0.23% 68
2018
Q2
$904K Hold
16,337
0.21% 72
2018
Q1
$1.03M Sell
16,337
-1,425
-8% -$91.7K 0.26% 65
2017
Q4
$1.09M Buy
17,762
+204
+1% +$12.8K 0.27% 64
2017
Q3
$1.12M Sell
17,558
-400
-2% -$23.4K 0.3% 63
2017
Q2
$1M Buy
17,958
+2,600
+17% +$141K 0.28% 62
2017
Q1
$835K Sell
15,358
-415
-3% -$22.8K 0.24% 69
2016
Q4
$921K Sell
15,773
-640
-4% -$35K 0.28% 66
2016
Q3
$885K Sell
16,413
-70
-0.4% -$4.5K 0.28% 66
2016
Q2
$1.21M Hold
16,483
0.38% 59
2016
Q1
$1.05M Sell
16,483
-530
-3% -$33.4K 0.34% 63
2015
Q4
$1.17M Sell
17,013
-37
-0.2% -$2.44K 0.39% 59
2015
Q3
$1.01M Sell
17,050
-525
-3% -$33.3K 0.36% 61
2015
Q2
$1.17M Sell
17,575
-1,756
-9% -$116K 0.4% 58
2015
Q1
$1.25M Sell
19,331
-85
-0.4% -$5.32K 0.42% 62
2014
Q4
$1.15M Buy
19,416
+2,181
+13% +$123K 0.39% 60
2014
Q3
$883K Hold
17,235
0.33% 63
2014
Q2
$836K Buy
17,235
+1,467
+9% +$72.3K 0.32% 62
2014
Q1
$819K Buy
15,768
+200
+1% +$10.6K 0.32% 62
2013
Q4
$828K Buy
15,568
+546
+4% +$27.8K 0.33% 61
2013
Q3
$696K Buy
15,022
+3,225
+27% +$142K 0.3% 66
2013
Q2
$527K Buy
+11,797
New +$512K 0.25% 70

Other funds holding BMY

Bath Savings Trust's BMY Position: Q2 2026 in Review

Bath Savings Trust held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 8,080 shares worth $466K. The position accounts for 0.05% of the portfolio, ranked #132.

Bath Savings Trust first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.55M in Q4 2019. 888 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Bath Savings Trust held 8,080 shares of Bristol-Myers Squibb worth $466K as of Q2 2026.
  • Bath Savings Trust left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.05% of Bath Savings Trust's portfolio in Q2 2026, its #132 holding.
  • Bath Savings Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • Bath Savings Trust's Bristol-Myers Squibb position peaked at $1.55M in Q4 2019.
  • 888 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Bath Savings Trust's 13F filing for Q2 2026, filed 9 Jul 2026.